We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
Fortunately, childhood brain tumors are very rare. Despite progress made over recent years, however, childhood brain tumors tend to be linked to poor prognoses coupled with low survival rates.
Dr Alexander Beck worked in Boston, USA as a fellow in pediatric neuro-oncology, later returning to his home country of Germany to establish a laboratory at the Ludwig Maximilian University of Munich. His current research is focused on pediatric brain tumors and drug translation.
Most of our work is funded by donations and every donation counts. Our main focus is on diffuse intrinsic pontine glioma, a brain tumor that usually affects children between five and nine years of age, with no significant long-term survival beyond five years. Progress in this area is very difficult, and so the emphasis is on the rapid translation of drugs that we can give children now, looking at approved drugs that we can repurpose, as well as working with pharmaceutical companies to develop new therapeutics.”
Dr Alexander Beck, Ludwig Maximilian University of Munich
The INTEGRA family of products have been an essential addition to the laboratory since the very beginning. The laboratory has made particular use of the ASSIST PLUS pipetting robot, the VOYAGER adjustable tip spacing pipettes, the EVOLVE manual pipettes and the PIPETBOY acu 2 pipette controller.
Dr Beck elaborates, “We needed to purchase a range of equipment to set up our facility, and I began by acquiring a VACUBOY for liquid aspirations. The INTEGRA team then introduced me to their other products, and I purchased an ASSIST PLUS pipetting robot, as well as EVOLVE and VOYAGER pipettes and several PIPETBOY acu 2.”
“Our lab assesses drugs in terms of their efficacy on tumor cells, blood-brain barrier penetration, toxicity and, on a deeper level, the tumor biology,” highlights Dr Beck.
“To do this, we use tumor models derived from preclinical patient biopsy samples, as well as quite sophisticated brain organoid cultures, which are biologically very close to what we see in the primary tissue. Alongside this, we have blood-brain barrier models that allow us to test a drug’s ability to cross from the blood into the brain, as well as methods to study the neurotoxic potential of drugs to understand dose-limiting toxicities.
“These results are communicated to the clinicians on a case-by-case basis, as part of a highly individualized treatment approach. Although we don’t run huge preclinical trials, we try to keep the major clinical centers informed of our findings, as this allows them to use these drugs in broader clinical trials to evaluate the potential significance of our results.
“In cases with an extremely poor prognosis, we can even recommend drugs that are in the very early stages of clinical development, although we still need some human toxicity data before suggesting treatment.”
Image Credit: Ludwig Maximilian University of Munich
The ASSIST PLUS pipetting robot is without doubt the system that has had the most impact on our work; I don’t think there is anything else out there with the same capabilities, especially for its price point. We do a large amount of cell culture, and have set up an ASSIST PLUS workflow to test a lot of drugs weekly. Initially, we seed 96 or 384 well plates of tumor cells, then perform drug dilutions and the drug treatment.
Dr Alexander Beck, Ludwig Maximilian University of Munich
Dr Beck continued, “Finally, the system is used for the viability assay. We can test 20 to 30 plates a week – a much higher throughput than manual processing, where we could process two plates a week – and, at the same time, free up time for other tasks thanks to its automation abilities.”
The ASSIST PLUS pipetting robot and VIALAB software facilitate the quick, easy creation of automated pipetting protocols.
Dr Beck highlights the software’s user-friendliness and intuitiveness, “The software is super intuitive – it’s as easy to use as a smartphone – and it also lets us simulate programs, helping to prevent mistakes before they are made. Medical students don’t always have a lot of lab experience but, thanks to our automation, we just have to teach them basic cell culture techniques. The rest is then carried out by the robot, which is a huge benefit in terms of reproducibility.”
The VOYAGER pipettes on the ASSIST PLUS have enabled the laboratory to considerably increase throughput, making the process more accurate and faster.
We are now optimizing the use of a six channel VOYAGER with wide bore tips on the ASSIST PLUS, to transfer embryoid bodies from 96 to 24 well plates. Automating this process would ensure that no embryoid body is missed and could reduce the workflow from hours to just a matter of minutes.
Dr Alexander Beck, Ludwig Maximilian University of Munich
“Previously, this had to be done with a single channel pipette, transferring the bodies one by one; it wasn’t even possible using a fixed space multichannel pipette due to the difference in spacing between the well plates.” Added Dr Beck.
The level of automation afforded with INTEGRA instruments has significantly helped to improve life in the laboratory.
Traditional pipettes employ a single rotating plunger to set volumes. This is often a long, tedious process, particularly when switching between lower and higher volumes. To help make this process more efficient, EVOLVE pipettes feature three quick set dials, corresponding to each of the three volume digits.
Dr Beck summarizes the benefits of using the EVOLVE pipettes, “The EVOLVE pipettes make such a difference to our work too; the quick set dials allow us to change dispensing volumes with ease, making our workflows faster and more streamlined. We have over 30 of these pipettes now and they are very comfortable to handle.
“The GripTips pipette tips are very beneficial too. When you're conducting as much work as we are, it’s great to know that you don’t have to worry about losing tips or samples! Although translational research for brain tumors is certainly a challenging field, our INTEGRA portfolio is helping us along the way.”
INTEGRA provides innovative solutions for Liquid Handling and Media Preparation applications which serve the needs of their customers in research, diagnostics and quality control laboratories.
Their instruments and plastic consumables are developed and manufactured in Zizers, Switzerland and Hudson, NH USA. In order to remain close to their customers, they maintain a direct sales and support organization in North America, the UK, France and Germany, as well as a network of over 100 highly trained distribution partners worldwide.
In recent years they have focused on developing a new and technologically advanced range of handheld electronic pipettes which are simple to use and meet the ergonomic needs of their customers. Today they are proud to offer the widest range of electronic pipettes in the market spanning a range from single channel pipettes up to 384 channel bench-top instruments.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and iform site visitors interested in medical research, science, medical devices and treatments.
Last updated: Jun 1, 2021 at 5:45 AM
Please use one of the following formats to cite this article in your essay, paper or report:
INTEGRA Biosciences. (2021, June 01). The Fight Against Childhood Brain Tumors. News-Medical. Retrieved on December 23, 2021 from https://www.news-medical.net/whitepaper/20210531/The-Fight-Against-Childhood-Brain-Tumors.aspx.
INTEGRA Biosciences. "The Fight Against Childhood Brain Tumors". News-Medical. 23 December 2021. <https://www.news-medical.net/whitepaper/20210531/The-Fight-Against-Childhood-Brain-Tumors.aspx>.
INTEGRA Biosciences. "The Fight Against Childhood Brain Tumors". News-Medical. https://www.news-medical.net/whitepaper/20210531/The-Fight-Against-Childhood-Brain-Tumors.aspx. (accessed December 23, 2021).
INTEGRA Biosciences. 2021. The Fight Against Childhood Brain Tumors. News-Medical, viewed 23 December 2021, https://www.news-medical.net/whitepaper/20210531/The-Fight-Against-Childhood-Brain-Tumors.aspx.
Accelerate Drug Discovery Research with the Correct Pipettes
Accelerate Your PCR Setup to Combat COVID-19
Advantages of Using a Peristaltic Pump to Transfer Liquids
Are You Using the Correct Micropipette?
ASSIST PLUS Provides Freedom from Routine Pipetting
Automating the human leukocyte antigen (HLA) workflow
Enabling Vital Screening for Microbial Evolution Research
Enhanced Chemical Resistance from Multichannel Reagent Reservoirs
Enhancing the Reproducibility of Serial Dilutions
Ergonomics of Pipette Use and Handling
Financial Benefits of Adjustable Tip Spacing Pipettes
Gain Flexibility in Virology Research with a Pipetting Robot
High Quality Blood Agar Production Using DOSE IT and MEDIA JET
How to Use Reagent Reservoirs to Overcome Dead Volume
Rapid Sample Transfer Between Differing Labware Formats
Scaling Liquid Handling Up Rapidly in Diagnostic Labs: Pandemic Readiness
The Divided Reservoir - A Rethink
Three Dimensional High-Throughput Assay Development
Top Tips for Handheld Pipetting
Using INTEGRA VIAFLO 96 System for Analysis of Drugs of Abuse
VIAFLO ASSIST Automates Early Stage Cell-Based Assay Development
What Should You Know About Good Laboratory Practice and Pipetting?
Why Ergonomic Pipetting in a Laboratory is Important
Professor Rishi Goyal and Professor Dennis Yi Tenen
In this interview, we speak to Professor Rishi Goyal and Professor Dennis Yi Tenen about their latest research that investigated COVID-19 vaccine hesitancy.
In this interview, we speak to Professor Scott H. Faro about his latest research that looked into COVID-19 and its complications within the central nervous system.
Since the start of the COVID-19 pandemic, variants have begun to emerge. We spoke to Jacob Heggestad about his rapid test that can detect these variants.
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.
This site complies with the HONcode standard for trustworthy health information: verify here.
News-Medical.net - An AZoNetwork Site
Owned and operated by AZoNetwork, © 2000-2021